Skip to main content
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(1):38–51. doi: 10.1111/j.1750-3639.2003.tb00005.x

Lymphoid Chemokines CCL19 and CCL21 are Expressed in the Central Nervous System During Experimental Autoimmune Encephalomyelitis: Implications for the Maintenance of Chronic Neuroinflammation

Sandra Columba‐Cabezas 1, Barbara Serafini Elena 1, Ambrosini, Francesca Aloisi 1,
PMCID: PMC8095989  PMID: 12580544

Abstract

The simultaneous presence of dendritic, T‐ and B‐cells in the central nervous system (CNS) of mice with experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, suggests that interactions among these cell types might be instrumental in the local induction and maintenance of autoimmune reactions. In this study, we explored the possibility that such aberrant leukocyte recruitment in the CNS could be sustained by “lymphoid” chemokines which orchestrate dendritic cell and lymphocyte homing to lymphoid organs. Transcripts for CCL19 and CCL21 and their common receptor CCR7 were induced in the CNS of mice undergoing relapsing‐remitting and chronic‐relapsing EAE. While CCL21 immunoreactivity was confined to the endothelium of some inflamed blood vessels, CCL19 was expressed by many infiltrating leukocytes and some astrocytes and microglia in the CNS parenchyma. CCR7+ cells accumulated in inflammatory lesions during EAE progression, when abundant infiltration of the CNS by mature dendritic cells, B‐cells and cells expressing naive T‐cell markers also occurred. These findings suggest that CCL19 and CCL21 produced in the EAE‐affected CNS may be critical for the homing of antigen presenting cells and lymphocytes, resulting in continuous local antigenic stimulation and maintenance of chronic neuroinflammation.

Full Text

The Full Text of this article is available as a PDF (817.6 KB).

S. C.‐C. and B. S. equally contributed to this work.

References

  • 1. Adams JC (1992) Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 40:1457–1463. [DOI] [PubMed] [Google Scholar]
  • 2. Archelos JJ, Hartung H‐P (2000) Pathogenic role of autoantibodies in neurological diseases. Trends Neurosci 23:317–327. [DOI] [PubMed] [Google Scholar]
  • 3. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schröder R, Deckert M, Schmidt S, Ravid R, Rajewsky K (2000) Clonal expansions of CD8+ T‐cells dominate the T‐cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Baekkevold ES, Yamanaka T, Palframan RT, Carlsen HS, Reinholt FP, von Andrian UH, Brandtzaeg P, Haraldsen G (2001) The CCR7 ligand ELC (CCL19) is transcytosed in high endothelial venules and mediates T‐cell recruitment. J Exp Med 193:1105–1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252. [DOI] [PubMed] [Google Scholar]
  • 6. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR (1999) B‐cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163:5133–5144. [PubMed] [Google Scholar]
  • 7. Bowman EP, Campbell JJ, Soler D, Dong Z, Manlongat N, Picarella D, Hardy RR, Butcher EC (2000) Developmental switches in chemokine response profiles during B‐cell differentiation and maturation. J Exp Med 191:1303–1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Breel M, Mebius RE, Kraal G (1987) Dendritic cells of the mouse recognized by two monoclonal antibodies. Eur J Immunol 17:1555–1559. [DOI] [PubMed] [Google Scholar]
  • 9. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA, Butcher EC (1998) Chemokines and the arrest of lymphocytes under flow conditions. Science 279:381–384. [DOI] [PubMed] [Google Scholar]
  • 10. Campbell JJ, Pan J, Butcher EC (1999) Developmental switches in chemokine responses during T‐cell maturation. J Immunol 163:2353–2357. [PubMed] [Google Scholar]
  • 11. Cannella B, Cross AH, Raine CS (1991) Relapsing autoimmune demyelination: a role for vascular addressins. J Neuroimmunol 35:295–300. [DOI] [PubMed] [Google Scholar]
  • 12. Chen S‐C, Leach MW, Chen Y, Cai X‐Y, Sullivan L, Wiekowski M, Dovey‐Hartman BJ, Zlotnik A, Lira SA (2002) Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J Immunol 168:1009–1017. [DOI] [PubMed] [Google Scholar]
  • 13. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi M, Mancardi GL, Ferrarini M (2000) Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164:2782–2798. [DOI] [PubMed] [Google Scholar]
  • 14. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, Butcher EC, Laudanna C (2000) Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759–769. [DOI] [PubMed] [Google Scholar]
  • 15. Cyster JG (1999) Chemokines and cell migration in secondary lymphoid organs. Science 286:2098–2102. [DOI] [PubMed] [Google Scholar]
  • 16. De Vos AF, van Meurs M, Brok HPM, Boon L, Rensing S't, Hart BA, Laman JD (2001) Transfer of CNS autoantigens and presentation in secondary lymphoid organs. J Neuroimmunol 118:75. [DOI] [PubMed] [Google Scholar]
  • 17. Di Rosa F, Serafini B, Scognamiglio P, Di Virgilio A, Finocchi L, Aloisi F, Barnaba V (2000) Short‐lived immunization site inflammation in self‐limited active experimental allergic encephalomyelitis. Int Immunol 12:711–719. [DOI] [PubMed] [Google Scholar]
  • 18. Drakesmith H, Chain B, Beverley P (2000) How can dendritic cells cause autoimmune disease Immunol Today 21:214–217. [DOI] [PubMed] [Google Scholar]
  • 19. Fan L, Reilly CR, Luo Y, Dorf ME, Lo D (2000) Ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol 164:3955–3959. [DOI] [PubMed] [Google Scholar]
  • 20. Förster R, Schubel A, Breitfeld D, Kremmer E, Renner‐Müller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99:23–33. [DOI] [PubMed] [Google Scholar]
  • 21. Furlan R, Poliani PL, Galbiati F, Bergami A, Grimaldi LM, Comi G, Adorini L, Martino G (1998) Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum Gene Ther 9:2605–2617. [DOI] [PubMed] [Google Scholar]
  • 22. Girard J‐P, Springer TA (1995) High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 16:449–457. [DOI] [PubMed] [Google Scholar]
  • 23. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, Nakano H (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189:451–460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Gunn MD, Tangemann K, Tam C, Cyster GC, Rosen SD, Williams LT (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95:258–263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Hjelmström P (2001) Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69:331–339. [PubMed] [Google Scholar]
  • 26. Hjelmström P, Fjell J, Nakagawa T, Sacca R, Cuff CA, Ruddle NH (2000) Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 156:1133–1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Issazadeh S, Ljungdahl A, Hojeberg B, Mustafa M, Olsson T (1995) Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin‐10, interleukin‐12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J Neuroimmunol 61:205–212. [DOI] [PubMed] [Google Scholar]
  • 28. Jonuleit H, Schmitt E, Steinbrink K, Enk AH (2001) Dendritic cells as a tool to induce anergic and regulatory T‐cells. Immunol Today 22:394–400. [DOI] [PubMed] [Google Scholar]
  • 29. Juedes AE, Hjelmström P, Bergman CM, Neild AL, Ruddle NH (2000) Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein‐induced experimental autoimmune encephalomyelitis. J Immunol 164:419–426. [DOI] [PubMed] [Google Scholar]
  • 30. Kellermann S‐A, Hudak S, Oldham ER, Liu Y‐J, McEvoy LM (1999) The CC chemokine receptor‐7 ligands 6Ckine and macrophage inflammatory protein‐3β are potent chemoattractants for in vitro‐ and in vivo‐derived dendritic cells. J Immunol 162:3859–3864. [PubMed] [Google Scholar]
  • 31. Kim CH, Pelus LM, White JR, Broxmeyer HE (1998) Macrophage‐inflammatory protein‐3β/EBI1 ‐ligand chemokine/CKb‐11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells. J Immunol 161:2580–2585. [PubMed] [Google Scholar]
  • 32. Kim CH, Rott LS, Clark‐Lewis I, Campbell DJ, Wu L, Butcher EC (2001) Subspecialization of CXCR5+ T‐cells: B helper activity is focalized in a germinal center‐localized subset of CXCR5+ T‐cells. J Exp Med 193:1373–138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Kratz A, Campos‐Neto A, Hanson MS, Ruddle NH (1996) Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 183:1461–1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Lehmann PV, Forsthuber T, Miller A, Sercarz EE (1992) Spreading of T‐cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155–157. [DOI] [PubMed] [Google Scholar]
  • 35. Lucchinetti CF, Bruck W, Lassmann H (1998) Multiple sclerosis: lessons learned from neuropathology. Semin Neurol 18:337–349. [DOI] [PubMed] [Google Scholar]
  • 36. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM (1998) Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 188:1493–1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Ludewig B, Odermatt B, Ochsenbein AF, Zinkernagel RM, Hengartner H (1999) Role of dendritic cells in the induction and maintenance of autoimmune diseases. Immunol Rev 169:45–54. [DOI] [PubMed] [Google Scholar]
  • 38. Luther SA, Tang LH, Hyman PL, Garr AG, Cyster JG (2000) Coexpression of the chemokines ELC and SLC by Tzone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 97:12694–12699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Matyszak MK, Perry VH (1996) The potential role of dendritic cells in immune‐mediated inflammatory diseases in the central nervous system. Neuroscience 74:599–608. [DOI] [PubMed] [Google Scholar]
  • 40. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M (1999) BCA‐1 is highly expressed in Helicobacter pylori‐induced mucosa‐associated lymphoid tissue and gastric lymphoma. J Clin Invest 104:R49–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nature Immunol 2:123–128. [DOI] [PubMed] [Google Scholar]
  • 42. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG (1999) Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T‐cell areas of the spleen. J Exp Med 189:403–412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Ngo VN, Tang LH, Cyster JG (1998) Epstein‐Barr virusinduced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T‐cells and activated B‐cells. J Exp Med 188:181–191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Noseworthy JH (1999) Progress in determining the causes and treatment of multiple sclerosis. Nature 399:A40–A47. [DOI] [PubMed] [Google Scholar]
  • 45. O'Neill JK, Butter C, Baker D, Gschmeissner SE, Kraal G, Butcher EC (1991) Expression of vascular addressins and ICAM‐1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology 72:520–525. [PMC free article] [PubMed] [Google Scholar]
  • 46. Pachynski RK, Wu SW, Gunn MD, Erle DJ (1998) Secondary lymphoid‐tissue chemokine (SLC) stimulates integrin α4β7‐mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule‐1 (MadCAM‐1) under flow. J Immunol 161:952–956. [PubMed] [Google Scholar]
  • 47. Pashenkov M, Huang Y‐M, Kostulas V, Haglund M, Södeström M, Link H (2001) Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124:480–492. [DOI] [PubMed] [Google Scholar]
  • 48. Prineas JW (1979) Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203:1123–1125. [DOI] [PubMed] [Google Scholar]
  • 49. Raine CS, Mokhtarian F, McFarlin DE (1984) Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest 51:534–546. [PubMed] [Google Scholar]
  • 50. Sallusto F, McKay CR, Lanzavecchia A (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18:593–620. [DOI] [PubMed] [Google Scholar]
  • 51. Serafini B, Columba‐Cabezas S, Di Rosa F, Aloisi F (2000) Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am J Pathol 157:1991–2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Steinman L (1999) Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511–514. [DOI] [PubMed] [Google Scholar]
  • 53. Suter T, Malipiero U, Otten L, Ludewig B, Muelethaler‐Mottet A, Mach B, Reith W, Fontana A (2000) Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis. Eur J Immunol 30:794–802. [DOI] [PubMed] [Google Scholar]
  • 54. Swain SL, Croft, M , Dubey C, Haynes L, Rogers P, Zhang X, Bradley LM (1996) From naive to memory T‐cells. Immunol Rev 150:143–167. [DOI] [PubMed] [Google Scholar]
  • 55. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ, Weyand CM (2001) Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167:1072–1080. [DOI] [PubMed] [Google Scholar]
  • 56. Targoni OS, Baus J, Hofstetter HH, Hesse MD, Karulin AY, Boehm BO, Forsthuber TG, Lehmann PV (2001) Frequencies of neuroantigen‐specific T‐cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J Immunol 166:4757–4764. [DOI] [PubMed] [Google Scholar]
  • 57. Tuohy VK, Yu M, Weinstock‐Guttman B, Kinkel RP (1997) Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest 99:1682–1690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Vassileva G, Soto H Zlotnik A, Nakano H, Kakiuchi T, Hedrick JA, Lira SA (1999) The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J Exp Med 190:1183–1188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Weninger W, Crowley MA, Manjunath N, von Andrian UH (2001) Migratory properties of naive, effector and memory CD8+ T‐cells. J Exp Med 194:953–966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Wingerchuk DM, Lucchinetti CF, Noseworthy JH (2001) Multiple sclerosis: current pathophysiological concepts. Lab Invest 81:263–281. [DOI] [PubMed] [Google Scholar]
  • 61. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y (1998) EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up‐regulated upon maturation. J Immunol 161:3096–3102. [PubMed] [Google Scholar]
  • 62. Yoshida R, Imai T, Hieshima K, Kusuda J, Baba M, Kitaura M, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O (1997) Molecular cloning of a novel human CC chemokine EBI1‐ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem 272:13803–13809. [DOI] [PubMed] [Google Scholar]
  • 63. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O (1998) Secondary lymphoid‐tissue chemokine is a functional ligand for the CC chemokine receptor CCR7. J Biol Chem 273:7118–7122. [DOI] [PubMed] [Google Scholar]
  • 64. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121–127. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES